Invex Therapeutics: Notice of AGM/Proxy Form/Notice of Access
Filed with ASX · · 102 pages · English
Summary by 6ix AI
Invex Therapeutics Ltd. has issued a notice for an upcoming General Meeting of Shareholders, scheduled for early December. The agenda includes several resolutions, such as approvals for acquisitions and share issuances related to a transaction with Rekover Therapeutics. Shareholders are advised to review the Independent Expert’s Report regarding the fairness of the proposed transactions. Voting by proxy is encouraged, with specific instructions provided for participation in the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Invex Therapeutics Ltd. on 6ix
Earlier from Invex Therapeutics
- Section 708A Cleansing Notice
- Application for quotation of securities - IXC
- Quarterly Activities/Appendix 4C Cash Flow Report
- Proposed issue of securities - IXC
- Invex to Acquire Rekover Therapeutics
Follow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics